Company |
Amount Raised |
Intarcia Therapeutics Inc. (November) |
$210M |
CureVac GmbH (September) |
$104.9M |
Relypsa Inc. (August) |
$80M |
Rib-X Pharmaceuticals Inc. (November) |
$67.5M |
Pearl Therapeutics Inc. (November) |
$65M |
bluebird bio (July) |
$60M |
ADC Therapeutics Sarl (March) |
$50M |
Aragon Pharmaceuticals Inc. (October) |
$50M |
Onconova Therapeutics Inc. (August) |
$50M |
Sangart Inc. (May) |
$50M |
Histogenics Corp. (July) |
$49M |